The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Chemotherapy-Related Cognitive Dysfunction
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Self-citationCandidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Self-citationAhles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Levin, V. A., Bidaut, L., Hou, P., Kumar, A. J., Wefel, J. S., Bekele, B. N., Prabhu, S., Loghin, M., Gilbert, M. R., & Jackson, E. F. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.061 · Cited by 729
Self-citationThe Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Lockman, P. R., Mittapalli, R. K., Taskar, K. S., Rudraraju, V., Gril, B., Bohn, K. A., Adkins, C. E., Roberts, A., Thorsheim, H. R., Gaasch, J. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1564 · Cited by 693
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Self-citationvan den Bent, M., Wefel, J., Schiff, D., Taphoorn, M., Jaeckle, K., Junck, L., Armstrong, T., Choucair, A., Waldman, A., Gorlia, T., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70057-2 · Cited by 645
Self-citationCognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Self-citationCognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2695 · Cited by 557
Koppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.0189 · Cited by 556
Self-citationAhles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0827 · Cited by 535
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010) · Cancer · doi:10.1002/cncr.25098 · Cited by 513
Self-citationJenkins, V, Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603029 · Cited by 407
Silverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Waddell, K., Petersen, L., Phelps, M. E., & Ganz, P. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9380-z · Cited by 397
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510905 · Cited by 396
Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q.-L., Hu, H., Chemerynsky, I., Clemons, M., Crump, M., Goss, P. E., Warr, D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.119 · Cited by 380
Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. (2007) · Cancer · doi:10.1002/cncr.22610 · Cited by 356
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., Uchitomi, Y., et al. (2007) · Cancer · doi:10.1002/cncr.22368 · Cited by 350
Cognitive function in breast cancer patients prior to adjuvant treatment
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9686-5 · Cited by 345
Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy
Dietrich, J., Monje, M., Wefel, J., & Meyers, C. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0130 · Cited by 341
Self-citation‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Self-citationMcDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1088-4 · Cited by 331
Cognitive impairment associated with adjuvant therapy in breast cancer
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006) · Psycho-Oncology · doi:10.1002/pon.964 · Cited by 320
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer
de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S. A. M., Nederveen, A. J., Boven, E., & Schagen, S. B. (2011) · Human Brain Mapping · doi:10.1002/hbm.21102 · Cited by 305
Self-citationSchagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj470 · Cited by 295
Self-citationFan, H. G. M., Houédé-Tchen, N., Yi, Q.-L., Chemerynsky, I., Downie, F. P., Sabate, K., & Tannock, I. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6550 · Cited by 280
Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Stock, J. V. D., Smeets, A., Christiaens, M., Leemans, A., Hecke, W. V., et al. (2011) · Human Brain Mapping · doi:10.1002/hbm.21033 · Cited by 275
de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., Lavini, C., Linn, S. C., Boven, E., van Dam, F. S. A. M., et al. (2012) · Human Brain Mapping · doi:10.1002/hbm.21422 · Cited by 273
Self-citationFerguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8639 · Cited by 272
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
Jansen, C. E., Cooper, B. A., Dodd, M. J., & Miaskowski, C. A. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0997-4 · Cited by 271
Schilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., Gundy, C. M., Huizenga, H. M., Nortier, J. W., van de Velde, C. J., van Dam, F. S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3553 · Cited by 269
Self-citationNeurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
Seigers, R., & Fardell, J. E. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.09.006 · Cited by 266
Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., Witmer, M., Van Gorp, W. G., Fornier, M., D'Andrea, G., et al. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00732.x · Cited by 264
Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., & van Dam, F. S. A. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf241 · Cited by 262
Self-citationRadiation therapy of brain tumors
Sheline, G. E. (1977) · Cancer · doi:10.1002/1097-0142(197702)39:2+<873::aid-cncr2820390725>3.0.co;2-y · Cited by 250
Neurological complications of radiotherapy and chemotherapy
Keime-Guibert, F., Napolitano, M., & Delattre, J.-Y. (1998) · Journal of Neurology · doi:10.1007/s004150050271 · Cited by 246
Cancer therapy-associated CNS neuropathology: an update and review of the literature
Perry, A., & Schmidt, R. E. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0023-y · Cited by 233
Prefrontal Cortex and Executive Function Impairments in Primary Breast Cancer
Kesler, S. R. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.245 · Cited by 224
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis
Monje, M., & Dietrich, J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.012 · Cited by 214
Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005) · The Breast · doi:10.1016/j.breast.2004.10.004 · Cited by 208
Correa, D. D., Maron, L., Harder, H., Klein, M., Armstrong, C. L., Calabrese, P., Bromberg, J. E. C., Abrey, L. E., Batchelor, T. T., & Schiff, D. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl464 · Cited by 186
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study
Quesnel, C., Savard, J., & Ivers, H. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0114-2 · Cited by 182
Pre‐treatment factors related to cognitive functioning in women newly diagnosed with breast cancer
Cimprich, B., So, H., Ronis, D. L., & Trask, C. (2005) · Psycho-Oncology · doi:10.1002/pon.821 · Cited by 172
Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment
Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009) · Psycho-Oncology · doi:10.1002/pon.1379 · Cited by 168
Wefel, J. S., Kayl, A. E., & Meyers, C. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601772 · Cited by 167
Self-citationGlobal and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy
Koppelmans, V., de Ruiter, M. B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., Vrooman, H., Niessen, W. J., Breteler, M. M. B., & Schagen, S. B. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1888-1 · Cited by 164
Self-citationAbraham, J., Haut, M. W., Morán, M. T. C., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.007 · Cited by 162
Prechemotherapy alterations in brain function in women with breast cancer
Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., Berman, M. G., Hayes, D. F., Noll, D. C., Peltier, S., et al. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903032537 · Cited by 161
Neurology and General Medicine
(2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06707-5.x5001-9 · Cited by 159
The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study
Stewart, A., Collins, B., MacKenzie, J., Tomiak, E. M., Verma, S., & Bielajew, C. H. (2007) · Psycho-Oncology · doi:10.1002/pon.1210 · Cited by 155
Cognitive functioning in breast cancer survivors: A controlled comparison
Jim, H., Donovan, K. A., Small, B. J., Andrykowski, M. A., Münster, P. N., & Jacobsen, P. B. (2009) · Cancer · doi:10.1002/cncr.24192 · Cited by 150
Jansen, C. E., Dodd, M. J., Miaskowski, C. A., Dowling, G. A., & Kramer, J. H. (2008) · Psycho-Oncology · doi:10.1002/pon.1342 · Cited by 146
Biglia, N., Bounous, V. E., Malabaila, A., PALMISANO, D., Torta, D. M. E., D’Alonzo, M., Sismondi, P., & Torta, R. (2011) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2011.01320.x · Cited by 141
Regional Brain Activation during Verbal Declarative Memory in Metastatic Breast Cancer
Kesler, S. R., Bennett, F. C., Mahaffey, M. L., & Spiegel, D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1227 · Cited by 140
Yamada, T. H., Denburg, N. L., Beglinger, L. J., & Schultz, S. K. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.1.48 · Cited by 137
Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients
Vearncombe, K., Rolfe, M. I., Wright, M. J., Pachana, N. A., Andrew, B., & Beadle, G. F. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990567 · Cited by 136
Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats
Konat, G. W., Kraszpulski, M., James, I., Zhang, H.-T., & Abraham, J. (2008) · Metabolic Brain Disease · doi:10.1007/s11011-008-9100-y · Cited by 133
Donovan, K. A., Small, B. J., Andrykowski, M. A., Schmitt, F. A., Münster, P. N., & Jacobsen, P. B. (2005) · Cancer · doi:10.1002/cncr.21482 · Cited by 133
Reid‐Arndt, S. A., Hsieh, C., & Perry, M. C. (2009) · Psycho-Oncology · doi:10.1002/pon.1581 · Cited by 132
Scherling, C., Collins, B., MacKenzie, J., Bielajew, C. H., & Smith, A. (2011) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2011.00122 · Cited by 126
Clinical trial end points for high-grade glioma: the evolving landscape
Reardon, D. A., Galanis, E., DeGroot, J. F., Cloughesy, T. F., Wefel, J. S., Lamborn, K. R., Lassman, A. B., Gilbert, M. R., Sampson, J. H., Wick, W., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq203 · Cited by 123
Self-citationSchilder, C. M. T., Eggens, P. C., Seynaeve, C., Linn, S. C., Boogerd, W. J., Gundy, C. M., Beex, L. V. A. M., van Dam, F. S. A. M., & Schagen, S. B. (2008) · Acta Oncologica · doi:10.1080/02841860802314738 · Cited by 122
Self-citationNeurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
Wefel, J. S., Cloughesy, T. F., Zazzali, J. L., Zheng, M., Prados, M., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor024 · Cited by 122
Self-citationNeural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy
Gong, X. W., Schwartz, P. H., Linskey, M. E., & Bota, D. A. (2011) · Neurology · doi:10.1212/wnl.0b013e318212a89f · Cited by 122
Reid‐Arndt, S. A., Yee, A., Perry, M. C., & Hsieh, C. (2009) · Journal of Psychosocial Oncology · doi:10.1080/07347330903183117 · Cited by 119
Brown, M. S., Stemmer, S. M., Simon, J. H., Stears, J. C., Jones, R. B., Cagnoni, P. J., & Sheeder, J. L. (1998) · PubMed Central · Cited by 118
Mehlsen, M. Y., Pedersen, A. D., Jensen, A. B., & Zachariae, R. H. (2008) · Psycho-Oncology · doi:10.1002/pon.1398 · Cited by 113
Correa, D. D., Rocco, M. M., DeAngelis, L. M., Dolgoff-Kaspar, R., IWAMOTO, F. M., Yahalom, J., & Abrey, L. E. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9716-0 · Cited by 112
Debess, J. E., Riis, J. Ø., Engebjerg, M. C., & Ewertz, M. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0756-8 · Cited by 112
Weis, J., Poppelreuter, M., & Bartsch, H. H. (2008) · Psycho-Oncology · doi:10.1002/pon.1472 · Cited by 112
Tager, F. A., McKinley, P. S., Schnabel, F. R., El-Tamer, M. B., Cheung, Y. K. K., Fang, Y., Golden, C. R., Frosch, M. E., Habif, U., Mulligan, M. M., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0606-8 · Cited by 111
Scherwath, A., Mehnert, A., Schleimer, B., Schirmer, L., Fehlauer, F., Kreienberg, R., Metzner, B., Thiel, E., Zander, A. R., Schulz‐Kindermann, F., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj108 · Cited by 111
Lyons, L., ELBeltagy, M., Bennett, G. W., & Wigmore, P. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030010 · Cited by 102
Potential Mechanisms for Chemotherapy-Induced Impairments in Cognitive Function
Jansen, C. E., Miaskowski, C. A., Dodd, M., Dowling, G. A., & Kramer, J. H. (2005) · Oncology nursing forum · doi:10.1188/05.onf.1151-1163 · Cited by 95
Ouimet, L. A., Stewart, A., Collins, B., Schindler, D. C., & Bielajew, C. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390801992725 · Cited by 81
Hilverda, K., Bosma, I., Heimans, J. J., Postma, T. J., Vandertop, W. P., Slotman, B. J., Buter, J., Reijneveld, J. C., & Klein, M. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9993-2 · Cited by 79
Vijayanathan, V., Gulinello, M. E., Ali, N. F., & Cole, P. D. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.006 · Cited by 77
5-Fluorouracil-induced leukoencephalopathy in patients with breast cancer
Choi, S. M., Lee, S., Yang, Y. S., Kim, B. C., Kim, M. K., & Cho, K. H. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.3.328 · Cited by 76
Neurologic Complications of Cancer Chemotherapy
Sul, J., & DeAngelis, L. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.006 · Cited by 75
No adverse effects of adjuvant chemotherapy on hippocampal volumein Japanese breast cancer survivors
Yoshikawa, E., Matsuoka, Y., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., Fujimori, M., Nakaya, N., Akizuki, N., Imoto, S., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-1412-6 · Cited by 72
Persistent Neurocognitive Problems After Adjuvant Chemotherapy for Breast Cancer
Kreukels, B. P. C., van Dam, F. S. A. M., Ridderinkhof, K. R., Boogerd, W. J., & Schagen, S. B. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.006 · Cited by 69
Self-citationNeurologic Complications of Chemotherapy and Radiation Therapy
Nolan, C. P., & DeAngelis, L. M. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000464179.81957.51 · Cited by 54
Groves, M. D., Maor, M. H., Meyers, C., Kyritsis, A. P., Jaeckle, K. A., Yung, W. K. A., Sawaya, R. A., Hess, K. R., Bruner, J. M., Peterson, P., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00122-4 · Cited by 53
Kvale, E. A., Clay, O. J., Ross, L. A., MCGEE, J. S., Edwards, J. D., Unverzagt, F. W., Ritchie, C. A., & Ball, K. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2008.01018.x · Cited by 43
Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study
Minisini, A. M., Faccio, S. D., Ermacora, P., et al. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.02.004 · Cited by 38
Mechanistic basis of adverse drugreactions: the perils of inappropriate dose schedules
Shah, R. R. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.1.103 · Cited by 37
Meyers, C. A. (2013) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2013.01.017 · Cited by 28
Neurological complications of chemotherapy and radiation therapy
Rosenfeld, M. R. (1997) · Revista Ecuatoriana de Neurologia · Cited by 24
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Self-citationIntercellular mitochondrial transfer as a means of tissue revitalization
Liu, D., Gao, Y., Liu, J., Huang, Y., Yin, J., Feng, Y., Shi, L., Meloni, B. P., Zhang, C., Zheng, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00440-z · Cited by 403
Gibson, E. M., Nagaraja, S., Ocampo, A., Tam, L. T., Wood, L. S., Pallegar, P. N., Greene, J. J., Geraghty, A. C., Goldstein, A. K., Ni, L., et al. (2019) · Cell · doi:10.1016/j.cell.2018.10.049 · Cited by 372
Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors
Kesler, S., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.02.004 · Cited by 300
“Exclusion criteria included (1) previous chemotherapy treatment; (2) major sensory deficit (eg, blindness); (3) color blindness, because some of the training tasks and cognitive tests relied on color; (4) neurologic or major medical conditions known to affect cognitive function; (5) history of inpatient psychiatric ho…”
Background
Metadata
- Authors
- Wefel, J. S., & Schagen, S. B.
- Venue
- Current Neurology and Neuroscience Reports
- Published
- 2012-03-28
- Volume
- 12
- Issue
- 3
- Pages
- 267-275
- ISSN
- 1528-4042 (ISSN-L)
- 1534-6293
- OpenAlex
- W2078207478
- Cited by
- 398
- References
- 92
- FWCI
- 20.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.